Skip to content

Dr. Vinck - Verplaetse

Active Private limited companyfounded 1998active for 28 yearsSt. Elooiskeer 13, 9770 KruisemKBO/BCE: BE 0463.732.155

Lifetime

20 annual accounts with figures on one time axis, 27 filings since 1999
peak of €456,159 in 2011
€301,726▲ 74.6%
lowest -€35,916 in 2017
€172,797▲ 145%
peak of €389,298 in 2025
€389,298▲ 34.5%
€235,530▲ 36.6%
peak of 0.7 FTE in 2006
-not published
Board2 names since 2013
2 directors and 1 other
Documentsfilings and deeds
25-08-202625 days late
2025micro format
Gross margin from €172,847 to €301,726Result from €70,654 to €172,797Dividend €72,958Equity from €289,460 to €389,298Debts from €172,472 to €235,530Cash from €60,929 to €211,961

Key points

from the 2025 annual accounts

Equity

€389,298 ▲ 34.5%
289,4602024+172,797Profit-72,958Dividend389,2982025

Dr. Vinck - Verplaetse paid out €72,958 in dividends. That is 42% of the 2025 profit.

Result

€172,797 ▲ 145%
€70,7002024€173,0002025

The result rose in 2025 from €70,654 to €172,797.

Filings

27 annual accounts since 1999
AprilJune31 JulyOctober200020102020

Seven of the last ten came late. The 2019 accounts came in latest, 83 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as Dr. Vinck - Verplaetse has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for Dr. Vinck - Verplaetse. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0463732155
Purpose change · Amendment of the articles “nieuwe bepaling artikel 3” (deed in Dutch) · Gazette deed
Capital increase The capital fell from €132,000 to €18,600 · Gazette deed
Capital increase of €113,400 to €132,000 The capital rose from €18,600 to €132,000 · Gazette deed
All 41 events

Official details

Source: KBO
Status
Active since 15-07-1998Normal situation
Activity
“De uitoefening van de geneeskunde door de artsen- aandeelhouders, meer bepaald van de geneeskunde…” (deed in Dutch)From the articles, 10 activities1 activity on the establishment unit
Establishment unit
2.229.357.8299770 Kruisem, since 08-07-1998
Financial year end
31 December
Peppol
Reachable since 21-11-2025
Company details

Annual accounts 2025

≈ €610,000estimated
€624,828▲ 35.3%
Filing
Filed on 25-08-2026
Financials

Insights on Dr. Vinck - Verplaetse

Dr. Vinck - Verplaetse files the micro format. That format states no turnover. The gross margin rose from €70,804 in 2006 to €301,726 in 2025.

The balance sheet grew most from 2007 to 2008 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Vinck - Verplaetse

What is the company number of Dr. Vinck - Verplaetse?
The company number of Dr. Vinck - Verplaetse is 0463.732.155. The VAT number is the same number with BE in front: BE 0463.732.155.
Where is Dr. Vinck - Verplaetse based?
The registered office is at St. Elooiskeer 13, 9770 Kruisem.Company details
What is the legal form of Dr. Vinck - Verplaetse?
Dr. Vinck - Verplaetse is a private limited company (BV).
When was Dr. Vinck - Verplaetse founded?
Dr. Vinck - Verplaetse was founded on 15-07-1998.
Is Dr. Vinck - Verplaetse still active?
Yes, Dr. Vinck - Verplaetse is an active enterprise in the KBO register.
How many employees does Dr. Vinck - Verplaetse have?
Dr. Vinck - Verplaetse had an average of 0.2 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
What is the turnover of Dr. Vinck - Verplaetse?
The turnover in financial year 2025 is ≈ €610,000. This figure is estimated from the gross margin of €301,726 and 1,019 comparable companies of the same size. It probably lies between €420,000 and €880,000. It is a rough estimate.
Is Dr. Vinck - Verplaetse profitable?
In financial year 2025, Dr. Vinck - Verplaetse made a profit of €172,797.
Where can I find the annual accounts of Dr. Vinck - Verplaetse?
Dr. Vinck - Verplaetse filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Vinck - Verplaetse due?
Dr. Vinck - Verplaetse must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.